Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

Recruiting now · Not applicable

Conditions studied: Upper Endoscopy, GLP1-R-related Disease

In brief

The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.

Key facts

Study ID

NCT07006142

Run by

Mayo Clinic

People needed

150

Starts

2025-08-01

Expected to finish

2026-08-30

Last updated by the study team

2026-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing elective upper endoscopy with gastroenterology team

You may not qualify if…

• Urgent or emergent procedure
• Inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure
• Upper GI barium study performed in past 24 hours.
• Gastroparesis
• Achalasia
• Pancreatitis
• Use of outpatient pro-motility medications
• Patient refusal
• Inability for patient to provide own consent

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.